相关实验视频

Updated: May 15, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

分层响应多价值四面体DNA框架装饰的CRISPR-Cas12a纳米囊使精确和增强的瘤化疗成为可能

Ye Zhang¹, Wenbin Li¹, Siting Chen^2,3

¹Department of Laboratory Medicine, Medical Research Center of Nanfang Hospital, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P. R. China.

|May 14, 2025

概括

一个新的DNA纳米结构-CRISPR-12a系统,Tatna,通过选择性地提供化疗药物和降低毒性,提供向癌症治疗. 这种系统提高了治疗效率,并最大限度地减少了非目标效应,从而改善了患者的治疗结果.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
癌症治疗癌症治疗

背景情况:

传统化疗在选择性瘤向方面面临挑战,并表现出高毒性.
开发先进的药物输送系统对于提高癌症治疗效率和减少副作用至关重要.

研究的目的:

开发一种自我控制的,三重锁定级联瘤治疗纳米囊 (Tatna),用于高效和有针对性的癌症治疗.
将DNA纳米结构与CRISPR-12a技术集成,以实现精确的药物输送和增强治疗结果.

主要方法:

塔塔纳将DNA四面体 (DTs),Cas12a/crRNA核糖蛋白 (Cas12a RNP) 和 doxorubicin (DOX) 结合在一个pH响应的PLGA纳米囊中.
一种向核素的阿巴胺促进了选择性瘤细胞内化.
通过APE1 mRNA激活Cas12a RNP会触发药物释放和诱导亡.

主要成果:

塔塔娜证明了选择性瘤向和有效的内部化进入癌细胞.
该纳米囊在酸性瘤微环境中提供了DOX和Cas12a的受控释放.
该系统有效地诱导瘤细胞的亡,提高治疗效率.

结论:

塔塔纳代表了一个可编程的,针对瘤的传递系统,用于先进的癌症治疗.
这种多功能纳米囊增强了化疗的疗效,同时最大限度地减少了非目标毒性.
开发的系统对精准医学和个性化癌症治疗策略具有前景.

关键词:

这就是CRISPR-Cas12a.DNA是四面体的四面体.化学疗法化疗化疗德克索鲁比辛 (doxorubicin) 是一种药物.有层次的响应性的响应.

更多相关视频

Preparation of Multifunctional Silk-Based Microcapsules Loaded with DNA Plasmids Encoding RNA Aptamers and Riboswitches

Preparation of Multifunctional Silk-Based Microcapsules Loaded with DNA Plasmids Encoding RNA Aptamers and Riboswitches

Published on: October 8, 2021

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...